Novel point mutation in exon 12 of the glucose-6- phosphate dehydrogenase gene: G6PD FLORES.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15065213)

Published in J Clin Lab Anal on January 01, 2004

Authors

Maria-Odete Rodrigues1, Júlia Dias Pereira, Gisela Gaspar, Gabriel Olim, Maria-Do-Carmo Martins, Carolino Monteiro

Author Affiliations

1: Instituto Nacional de Saúde, Laboratório de Química Clínica, Lisboa, Portugal.

Articles by these authors

Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Rev Port Cardiol (2005) 1.47

Kalirin: a novel genetic risk factor for ischemic stroke. Hum Genet (2010) 1.07

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet (2010) 0.92

TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches. J Cereb Blood Flow Metab (2012) 0.91

Glucose-6-phosphate dehydrogenase deficiency in Portugal: biochemical and mutational profiles, heterogeneity, and haplotype association. Blood Cells Mol Dis (2002) 0.90

Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med Genet (2008) 0.89

High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort. BMC Med Genet (2012) 0.88

Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility. Atherosclerosis (2011) 0.87

Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions. J Cereb Blood Flow Metab (2011) 0.86

DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types. Int J Oncol (2007) 0.84

Differential expression of CDC25 phosphatases splice variants in human breast cancer cells. Clin Chem Lab Med (2011) 0.84

eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Oncol Rep (2009) 0.81

Differential expression of GSPT1 GGCn alleles in cancer. Cancer Genet Cytogenet (2009) 0.80

Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. Clin Chem Lab Med (2005) 0.80

Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach. Drug Metabol Drug Interact (2013) 0.80

Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines. Mol Oncol (2012) 0.79

Translation termination and protein folding pathway genes are not correlated in gastric cancer. Clin Chem Lab Med (2009) 0.78

Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism. J Hum Genet (2008) 0.78

Conference scene: pharmacogenomics: from cell to clinic (part 2). Pharmacogenomics (2014) 0.75

Identification of a 0.4 Kb deletion region in 10q26 associated with endometrial carcinoma. Oncol Rep (2010) 0.75

Pharmacogenomics: from cell to clinic (Part 1). Pharmacogenomics (2014) 0.75